New Multivalent Cationic Lipids Reveal Bell Curve for Transfection Efficiency Versus Membrane Charge Density: Lipid-DNA Complexes for Gene Delivery
Overview
Molecular Biology
Affiliations
Background: Gene carriers based on lipids or polymers-rather than on engineered viruses-constitute the latest technique for delivering genes into cells for gene therapy. Cationic liposome-DNA (CL-DNA) complexes have emerged as leading nonviral vectors in worldwide gene therapy clinical trials. To arrive at therapeutic dosages, however, their efficiency requires substantial further improvement.
Methods: Newly synthesized multivalent lipids (MVLs) enable control of headgroup charge and size. Complexes comprised of MVLs and DNA have been characterized by X-ray diffraction and ethidium bromide displacement assays. Their transfection efficiency (TE) in L-cells was measured with a luciferase assay.
Results: Plots of TE versus the membrane charge density (sigmaM, average charge/unit area of membrane) for the MVLs and monovalent 2,3-dioleyloxypropyltrimethylammonium chloride (DOTAP) merge onto a universal, bell-shaped curve. This bell curve leads to the identification of three distinct regimes, related to interactions between complexes and cells: at low sigmaM, TE increases with increasing sigmaM; at intermediate sigmaM, TE exhibits saturated behavior; and unexpectedly, at high sigmaM, TE decreases with increasing sigmaM.
Conclusions: Complexes with low sigmaM remain trapped in the endosome. In the high sigmaM regime, accessible for the first time with the new MVLs, complexes escape by overcoming a kinetic barrier to fusion with the endosomal membrane (activated fusion), yet they exhibit a reduced level of efficiency, presumably due to the inability of the DNA to dissociate from the highly charged membranes in the cytosol. The intermediate, optimal regime reflects a compromise between the opposing demands on sigmaM for endosomal escape and dissociation in the cytosol.
Boosting Lipofection Efficiency Through Enhanced Membrane Fusion Mechanisms.
Pavlov R, Akimov S, Dashinimaev E, Bashkirov P Int J Mol Sci. 2025; 25(24.
PMID: 39769303 PMC: 11677079. DOI: 10.3390/ijms252413540.
He W, Kirmizialtin S Biomacromolecules. 2024; 25(8):4819-4830.
PMID: 39011747 PMC: 11323003. DOI: 10.1021/acs.biomac.4c00192.
Steffes V, MacDonald S, Crowe J, Murali M, Ewert K, Li Y Eur Phys J E Soft Matter. 2023; 46(12):128.
PMID: 38099960 PMC: 10802834. DOI: 10.1140/epje/s10189-023-00388-2.
Steffes V, Zhang Z, Ewert K, Safinya C Langmuir. 2023; 39(50):18424-18436.
PMID: 38051205 PMC: 10799670. DOI: 10.1021/acs.langmuir.3c02664.
Looking Back, Moving Forward: Lipid Nanoparticles as a Promising Frontier in Gene Delivery.
Pozzi D, Caracciolo G ACS Pharmacol Transl Sci. 2023; 6(11):1561-1573.
PMID: 37974625 PMC: 10644400. DOI: 10.1021/acsptsci.3c00185.